BioMarCare is a portfolio company of Hadasit Bio-Holdings, a publicly traded holding company for businesses using intellectual property developed and owned by Israel's Hadassah University Hospital.

Israel-listed Micromedic has invested $1m in BioMarCare Technologies, with an option to invest an additional $1m in the local biotech company.

BioMarCare is a portfolio company of Hadasit Bio-Holdings, a publicly traded holding company for businesses using intellectual property developed and owned by Israel’s Hadassah University Hospital.

Ophir Shahaf, chief executive of Hadasit Bio-Holdings, said: "The investment validates the technology and research behind BioMarCare’s diagnostic kits.

"Not only will the agreement secure funds to advance the research and…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?